Finn Therapeutics Ltd
Company Profile
live
MicroFinn Therapeutics Ltd
ni672275•Private Limited With Share Capital
Glendinning House, 6 Murray Street, Belfast, BT16DN
Get Full Access
Incorporated
02/09/2020
Company Age
5 years
Directors
1
Employees
2
SIC Code
72110
Risk
high risk
Company Overview
Registration, classification & business activity
Finn Therapeutics Ltd (ni672275) is a private limited with share capital incorporated on 02/09/2020 (5 years old) and registered in belfast, BT16DN. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Private Limited With Share Capital
SIC: 72110
Micro
Incorporated 02/09/2020
BT16DN
2 employees
Financial Overview
Total Assets
£39.2K
Liabilities
£58.7K
Net Assets
£-19.5K
Cash
£0
Key Metrics
2
Employees
1
Directors
20
Shareholders
1
Patents
Filed Documents
35
Document Name
Category
Date
Capital Cancellation Shares
Category:Capital
Date:23-04-2026
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:16-04-2026
Termination Director Company With Name Termination Date
Category:Officers
Date:19-12-2025
Legacy
Category:Capital
Date:21-10-2025
Capital Statement Capital Company With Date Currency Figure
Category:Capital
Date:21-10-2025
Legacy
Category:Insolvency
Date:21-10-2025
Resolution
Category:Resolution
Date:21-10-2025
Capital Cancellation Shares
Category:Capital
Date:15-10-2025
Resolution
Category:Resolution
Date:08-10-2025
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:18-07-2025
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:18-07-2025
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:25-06-2025
Change Account Reference Date Company Previous Shortened
Category:Accounts
Date:28-05-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:18-02-2025
Resolution
Category:Resolution
Date:18-02-2025
Capital Allotment Shares
Category:Capital
Date:17-02-2025
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:14-10-2024
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:27-09-2024
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:09-10-2023
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:25-09-2023
Appoint Person Director Company With Name Date
Category:Officers
Date:13-09-2023
Termination Director Company With Name Termination Date
Category:Officers
Date:13-09-2023
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:06-10-2022
Accounts With Accounts Type Micro Entity
Category:Accounts
Date:01-09-2022
Change Account Reference Date Company Previous Extended
Category:Accounts
Date:25-05-2022
Confirmation Statement With Updates
Category:Confirmation Statement
Date:20-10-2021
Resolution
Category:Resolution
Date:07-09-2021
Resolution
Category:Resolution
Date:07-09-2021
Memorandum Articles
Category:Incorporation
Date:03-09-2021
Capital Alter Shares Subdivision
Category:Capital
Date:03-09-2021
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:02-09-2021
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:02-09-2021
Appoint Person Director Company With Name Date
Category:Officers
Date:02-09-2021
Capital Allotment Shares
Category:Capital
Date:02-09-2021
Incorporation Company
Category:Incorporation
Date:02-09-2020
Innovate Grants
1
This company received a grant of £98440.0 for Proof Of Concept - Novel Anti-Angiogenic Therapeutic For Renal Cell Carcinoma. The project started on 01/08/2024 and ended on 31/08/2025.
Risk Assessment
high risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typemicro-entity accounts
Due Date30/09/2027
Filing Date16/04/2026
Latest Accounts31/12/2025
Trading Addresses
Glendinning House, 6 Murray Street, Belfast, BT16DNRegistered
Related Companies
2
Contact
Glendinning House, 6 Murray Street, Belfast, BT16DN